RMG Wealth Management’s Gilead Sciences GILD Stock Holding History

RMG Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15	Closed	-$1.98K	–	617
2025 Q4	$1.98K	Buy	+15	New	+$1.82K	﹤0.01%	358

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

RMG Wealth Management's GILD Position: Q1 2026 in Review

RMG Wealth Management sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 15 shares — an estimated $1.98K sold.

RMG Wealth Management first reported a position in GILD in Q4 2025 and held it in 1 quarter. The position peaked at $1.98K in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

RMG Wealth Management reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
RMG Wealth Management sold 15 Gilead Sciences shares in Q1 2026, an estimated $1.98K.
RMG Wealth Management first reported a position in Gilead Sciences in Q4 2025 and held it in 1 quarter.
RMG Wealth Management's Gilead Sciences position peaked at $1.98K in Q4 2025.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on RMG Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.